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 SARCOPENIA is defi ned as the gradual decline in skel-etal muscle mass and strength with aging. On a myocel-
lular level, sarcopenia is characterized by a reduction in the 
number of both Type I and II muscle fi bers ( 1 ) and specifi c 
Type II muscle fi ber atrophy ( 1 – 4 ). In skeletal muscle tis-
sue, satellite cells (SCs) are essential for myofi ber repair, 
maintenance, and growth ( 5 – 8 ). As such, an age-related de-
cline in SC number and/or function could have an important 
role in the etiology of sarcopenia. Previous studies have ei-
ther shown a similar ( 2 , 9 – 11 ) or lower ( 12 , 13 ) SC content 
in older adults when compared with young adults. Recently, 
we reported that Type II muscle fi ber atrophy in older adults 
is associated with a specifi c decline in Type II muscle fi ber 
SC content ( 4 ). The latter likely explains the discrepant 
fi ndings in previous studies that only assessed SC content in 
mixed muscle tissue. 
 Resistance type exercise training has been shown to rep-
resent an effective interventional strategy to augment muscle 
mass, strength, and function in older adults ( 14 – 19 ). Previ-
ous studies in older adults have shown that the muscle adap-
tive response to resistance training is characterized by Type II 
muscle fi ber hypertrophy ( 16 – 19 ). For muscle fi ber hyper-
trophy to occur beyond a certain threshold, the addition of 
new myonuclei is essential. The latter is facilitated by the 
proliferation of SCs and the differentiation of their progeny 
into new myonuclei that fuse with existing muscle fi bers ( 7 , 
 8 , 20 ). Though the exact signaling pathways leading to mus-
cle hypertrophy following resistance type exercise remain to 
be elucidated, it seems evident that an increase in the num-
ber of SCs is needed to allow the muscle adaptive response 
to occur. In accordance, some studies ( 21 , 22 ) have reported 
an upregulation of the number of SCs in mixed muscle tis-
sue following exercise training in older adults. However, 
others have failed to confi rm these fi ndings ( 9 , 23 ). The ap-
parent discrepancy in the literature is likely attributed to the 
lack of fi ber type – specifi c data on this topic. We hypothe-
sized that resistance type exercise training in older adults 
increases SC content in a fi ber type – specifi c manner, thereby 
allowing Type II muscle fi ber hypertrophy. 
 The present study aims to assess the impact of a 3-month 
resistance type exercise training program on muscle strength, 
body composition, and muscle fi ber type – specifi c charac-
teristics in healthy, elderly men. Skeletal muscle biopsies 
were collected before and after completion of the exercise 
intervention program to determine the impact of resistance 
type exercise training on muscle fi ber type – specifi c hyper-
trophy, myonuclei, and SC content in older adults. 
 Methods 
 Participants 
 A total of 14 healthy elderly men (aged 65 – 85 years) vol-
unteered to participate in a 12-week resistance type exercise 
intervention program (three sessions per week). One par-
ticipant dropped out during the study because of an acute 
back problem that occurred during gardening. Medical his-
tory of all participants was evaluated, and an oral glucose 
tolerance test (OGTT) and resting electrocardiogram were 
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performed before selection. Exclusion criteria were defi ned 
that would preclude successful participation in the exercise 
program and included (silent) cardiac or peripheral vascular 
disease, orthopedic limitations, and/or type 2 diabetes ( 24 ). 
The latter was used as an exclusion criterion as insulin resis-
tance and/or type 2 diabetes can strongly affect the process 
of muscle mass loss with aging ( 25 ). All participants were 
living independently and had not participated in any struc-
tured exercise training program over the past 5 y. 
 All participants were informed on the nature and possible 
risks of the experimental procedures, before written informed 
consent was obtained. All procedures were performed ac-
cording to the Declaration of Helsinki, and the study was 
approved by the Medical Ethics Committee of the Academic 
Hospital, Maastricht, the Netherlands. This study is part of a 
greater project investigating the clinical benefi ts of exercise 
intervention in older adults. 
 Study Design 
 After screening, all eligible participants were enrolled in 
a 12-week resistance type exercise intervention program. 
Before, during, and after the exercise intervention, anthro-
pometric measurements (height, body mass, leg volume) 
( 26 ), strength assessments, and computed tomography (CT) 
and dual-energy X-ray absorptiometry (DEXA) scans were 
performed and muscle biopsies, blood samples, and dietary 
intake records were collected. 
 Dietary Intake and Physical Activity Standardization 
 Standardized meals ( ~ 4.0 MJ: 57 Energy% [En%] carbo-
hydrate, 30 En% fat, and 13 En% protein) were provided to 
all participants prior to each test day, and participants were 
instructed to refrain from strenuous physical activity for 
3 days prior to testing. Dietary intake was recorded for 2 days 
prior to muscle biopsy and blood sample collection. These 
records were used to standardize food intake prior to muscle 
biopsy and blood sampling 4 days after cessation of the exer-
cise intervention program. On all test days, participants ar-
rived at the laboratory by car or public transportation, 
following an overnight fast. The latter was confi rmed by di-
etary intake records and further verifi ed by the assessment of 
basal blood glucose and insulin concentrations and blood 
lipid profi le. To assess potential changes in daily food intake 
that might have occurred during the intervention period, par-
ticipants recorded 3-day weighted dietary records (Thursday 
to Saturday), prior to the onset of the intervention program 
and in Week 11 of the exercise intervention. Food intake re-
cords were analyzed with Eetmeter software 2005, version 
1.4.0 (Voedingscentrum, the Hague, the Netherlands). 
 Strength Assessment 
 Maximum strength was assessed by means of one-repetition 
maximum (1RM) strength tests on regular leg press (LP) 
and leg extension (LE) machines (Technogym, Rotterdam, 
the Netherlands). During a familiarization trial, a proper 
lifting technique was demonstrated and practiced and maxi-
mum strength was estimated using the multiple-repetitions 
testing procedure ( 27 ). In an additional session, at least 
1 week before muscle biopsy collection, each participant’s 
1RM was determined as described previously ( 4 ). The 1RM 
tests were repeated following 4 and 8 weeks of intervention 
and after cessation of the intervention program, 2 days after 
the last exercise session. 
 Exercise Intervention Program 
 Supervised resistance type exercise training was per-
formed three times a week for a period of 12 weeks. Train-
ing consisted of 5 minutes of warming-up on a cycle 
ergometer, followed by four sets on both the LP and LE 
machines, and a 5-minute cooling-down period on the cycle 
ergometer. During the fi rst 4 weeks of training, the work-
load was increased from 60% of 1RM (10 – 15 repetitions in 
each set) to 75% of 1RM (8 – 10 repetitions). Starting at 
Week 5, four sets of eight repetitions were performed at 
75% – 80% of 1RM on each machine. Resting periods of 1.5 
and 3 minutes were allowed between sets and exercises, re-
spectively. Workload intensity was adjusted based on the 
1RM tests (Weeks 4 and 8). In addition, workload was in-
creased if more than eight repetitions could be performed in 
three out of four sets. Exercise sessions were always per-
formed in the morning, at the same time of day. Participants 
had breakfast 1.5 hours before each exercise session, and 
lunch 2 hours after each session. On average, participants 
attended 35  ± 1 of the 36 scheduled exercise sessions. 
 CT Scans 
 Anatomical cross-sectional area (CSA) of the quadriceps 
muscle was measured with a CT scanner (IDT 8000; Philips 
Medical Systems, Best, the Netherlands) prior to and after 
cessation of the exercise intervention program (3 days after 
strength assessment and prior to muscle biopsy collection). 
With participants lying supine, legs extended, and their feet 
secured, a 3-mm-thick axial image (scanning characteris-
tics: 120 kV, 300 mA, rotation time of 0.75 seconds, and 
fi eld of view of 500 mm) was taken midway between the 
anterior superior iliac spine and the bottom of the patella. 
The exact scanning position was measured and marked, to 
be replicated after cessation of the intervention program. 
Using the described approach we determined the coeffi cient 
of variation for repeated scans to be 0.6%. Images were 
loaded onto a PC using AGFA IMPAX imaging software, 
version 5.2 (AGFA Healthcare , Brussels, Belgium). Muscle 
area of the right leg was selected between  − 29 and +150 
Hounsfi eld units ( 28 ), after which the quadriceps muscle 
was selected by manual tracing. Quadriceps CSA was cal-
culated using Lucia 4.81 software (Nikon Instruments Eu-
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performed by two investigators blinded to participant cod-
ing; intraclass correlation coeffi cients for inter- and intrain-
vestigator reliability were 0.997 and 0.998, respectively. 
 DEXA Scans 
 Directly after CT scanning, body composition and bone 
mineral content were measured with DEXA (Lunar Prodigy 
Advance; GE Healthcare, Madison, WI). Whole-body and 
regional lean mass, fat mass, and bone mineral content were 
determined using the system’s software package enCORE 
2005 (version 9.15.00 ); GE Healthcare. 
 Blood Samples 
 To determine glucose homeostasis  and exclude insulin-
resistant participants and/or participants with diabetes, fast-
ing blood samples were collected prior to the intervention, 
and 4 days after the strength assessment was performed af-
ter completion of the exercise program. Blood samples were 
collected in ethylenediaminetetraacetic acid (EDTA) – 
containing tubes and centrifuged at 1,000 g and 4°C for 
10 minutes. Aliquots of plasma were frozen in liquid nitro-
gen and stored at  − 80°C. Plasma samples were analyzed 
for glucose (COBAS FARA, Uni Kit III; Roche, Basel, 
Switzerland) and insulin concentrations (Insulin RIA Kit; 
LINCO Research Inc., St Charles, MO). Blood HbA1c con-
tent (3-mL blood sample, EDTA) was analyzed by high-
performance liquid chromatography (Bio-Rad Variant II; 
Bio-Rad , Munich, Germany). Plasma glucose and insulin 
concentrations from the OGTT were used to estimate whole-
body insulin sensitivity using the oral glucose insulin sensi-
tivity index ( 29 ). 
 Muscle Biopsies 
 Three days prior to the onset of exercise training and 
4 days after the postintervention strength assessment, mus-
cle biopsy samples were taken from the right leg of each 
participant, in the morning after an overnight fast. After lo-
cal anesthesia, percutaneous needle biopsies (50 – 80 mg) 
were taken from the vastus lateralis muscle,  ~ 15 cm above 
the patella ( 30 ). The posttraining biopsy was performed  ~ 1 cm 
proximal to the pretraining biopsy, at the same depth. Any 
visible nonmuscle tissue was removed from the biopsy sam-
ples, which were then embedded in Tissue-Tek (Sakura 
Finetek, Zoeterwoude, the Netherlands), immediately fro-
zen in liquid nitrogen – cooled isopentane, and stored at 
 – 80°C until further analyses. 
 Immunohistochemistry 
 From all biopsies, 5- m m-thick cryosections were cut at 
 – 20°C. Pre- and postintervention samples from one partici-
pant were mounted together on uncoated glass slides. Care 
was taken to properly align the samples for cross-sectional 
fi ber analyses. Serial cross-sections were stained for muscle 
fi ber typing (FT) and myocellular SC content as described 
previously ( 4 , 31 ). First antibodies used are directed against 
myosin heavy chain (MHC)-I  (A4.951, dilution 1:20; De-
velopmental Studies Hybridoma Bank, Iowa City, IA), lami-
nin (polyclonal rabbit anti-laminin, dilution 1:50; Sigma, 
Zwijndrecht, the Netherlands), and CD56 (dilution 1:40; 
BD Biosciences, San Jose, CA). The latter antibody has 
been extensively used for SC determination in human mus-
cle tissue ( 2 , 12 , 21 , 23 , 32 , 33 ). Appropriate secondary anti-
bodies were applied: goat anti-mouse IgG1 AlexaFluor488 
and goat anti-rabbit IgG AlexaFluor555 (dilution 1:500 and 
1:200; Molecular Probes, Invitrogen, Breda, the Nether-
lands, respectively) and Avidin-D (dilution 1:333; Vector 
Laboratories, Inc., Burlingame, CA), respectively. Nuclei 
were stained with 4,6-diamidino-2-phenylindole (DAPI, 
0.238  m M; Molecular Probes). Staining procedures were as 
follows. After fi xation (5 minutes acetone), slides were air-
dried and incubated for 60 minutes at room temperature 
with primary antibodies directed against laminin and either 
MHC-I or CD56, diluted in 0.05% Tween – phosphate-buff-
ered saline (PBS). Slides were then washed (3 × 5 minutes 
PBS). Slides for FT were then incubated for 30 minutes at 
room temperature with the appropriate secondary antibod-
ies, diluted together with DAPI in 0.05% Tween-PBS. For 
optimizing the staining result, slides for SCs were fi rst incu-
bated for 30 minutes with biotinylated horse anti-mouse IgG 
(dilution 1:150; Vector Laboratories, Inc.), diluted in PBS. 
After another washing step with PBS, SC slides were then 
incubated for 10 minutes with the secondary antibodies, di-
luted together with DAPI in 0.05% Tween-PBS. After a fi nal 
washing step, all slides were mounted with cover glasses 
using Mowiol (Calbiochem, Amsterdam, the Netherlands). 
Staining procedures resulted in laminin stained in red, nu-
clei in blue, and either MHC-I or CD56 in green ( Figure 1 ). 
 All images were digitally captured, using fl uorescence mi-
croscopy with a Nikon E800 fl uorescence microscope (Nikon 
Instruments Europe) coupled to a Basler A113 C progressive 
scan color CCD camera with a Bayer color fi lter. Epifl uores-
cence signal was recorded using a Texas Red excitation fi lter 
(540 – 580 nm) for laminin, a DAPI UV excitation fi lter (340 –
 380 nm) for the nuclei, and a fl uorescein isothiocyanate  exci-
tation fi lter (465 – 495 nm) for either MHC-I or CD56. Image 
processing and quantitative analyses were done using Lucia 
4.81 software package , as described previously ( 4 ). All im-
age recordings and analyses were performed by an investiga-
tor blinded to participant coding. 
 From the FT slides, images were captured at a 120× mag-
nifi cation. Laminin was used to determine the basement 
membrane, and all fi bers within each image were identifi ed 
as Type I or Type II fi ber ( Figure 1 ). Within each image, the 
number of fi bers, the mean fi ber cross-sectional area (CSA ), 
the number of myonuclei per fi ber, and the mean fi ber area 
per myonucleus (fi ber CSA/no. of myonuclei) were mea-
sured for the Type I and Type II muscle fi bers separately. To 
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number of nuclei was corrected for the number of SCs 
counted on the SC slides. Fiber circularity was calculated as 
(4 p ·CSA)/(perimeter) 2 ; all fi bers with circularity below 0.60 
were excluded from analysis ( 17 ). No differences in fi ber cir-
cularity were observed over time or between fi ber types, 
validating the comparison of pre- and posttraining data on 
muscle fi ber CSA. 
 From the SC slides, images were captured at a 240× mag-
nifi cation to allow clear determination of SC localization. 
Laminin was used to visualize cell borders. FT was deter-
mined by matching the serial FT slides. SCs were determined 
at the periphery of each fi ber and stained positive for both 
DNA (DAPI) and CD56 ( Figure 1 ). The number of SCs per 
muscle fi ber, the percentage of SCs [no. of SCs/(no. of SCs + 
no. of myonuclei) × 100], and the number of SCs per fi ber 
area (in square millimeters) were calculated for the Type I 
and Type II muscle fi bers separately. A mean total of 328  ± 31 
and 254  ± 37 muscle fi bers were analyzed in each partici-
pants ’ pre- and postintervention biopsy sample, respectively. 
 Statistics 
 All data are expressed as means  ± SEMs. Differences be-
tween pre- and postintervention values were analyzed with 
Student’s paired  t tests. In addition, two-way repeated mea-
sures analysis of variance with time (pre vs post) and fi ber 
type (Type I vs Type II) as within-participants factors was 
used to determine training-induced changes in muscle fi ber 
type – specifi c variables. In case of signifi cant interaction, 
Student’s paired  t tests were performed for time effects 
within Type I or Type II muscle fi ber characteristics, and/or 
effects of muscle fi ber type within the pre- or postinterven-
tion values. All analyses were performed using SPSS 
version 13.0 (SPSS, Chicago, IL). An  a -level of 0.05 was 
used to determine statistical signifi cance. 
 Results 
 Participants 
 Participants ’ characteristics at baseline and after inter-
vention are provided in  Table 1 . Participants ’ age averaged 
72  ± 2 years. Total body mass, height, and body mass index 
did not change over the intervention period. Fasting blood 
glucose and insulin concentrations and HbA1c contents 
were within normal range for healthy individuals and did 
not change over time ( Table 1 ). 
 Muscle Strength 
 Strength (1RM) increased signifi cantly from pre- to 
postintervention for both the LE and LP exercises, from 
88  ± 4 to 111  ± 5 kg and from 170  ± 8 to 210  ± 10 kg, re-
spectively ( p < .001). Repeated measures analysis revealed 
that the increase in 1RM strength was statistically signifi -
cant for each 4-week interval during the intervention period 
for both exercises (data not shown). 
 Body Composition and Muscle Mass 
 Whole-body lean mass tended to increase throughout 
the intervention period (from 57.4  ± 1.6 to 58.0  ± 1.7 kg; 
 p = .062). Total fat mass decreased signifi cantly ( p < .01), 
resulting in a signifi cant decline in whole-body fat per-
centage ( p < .01;  Table 2 ). Leg lean mass increased from 
18.3  ± 0.5 to 19.3  ± 0.5 kg ( p < .001). In accordance, fat 
percentage in the legs had also decreased following the 
exercise intervention ( p < .05;  Table 2 ). No changes were 
observed in whole-body and regional bone mineral con-
tent (data not shown). 
 CT scans of the upper leg, performed prior to and after the 
exercise program, revealed a substantial 8.8%  ± 1.4% increase 
in quadriceps ’ anatomical CSA following the intervention 
program, from 75.9  ± 3.7 to 82.4  ± 3.9 cm 2 ( p < .001). 
 Table 1.  Participants ’ Characteristics 
 Before After 
 Body mass (kg) 80.2  ± 3.4 80.1  ± 3.4 
 Height (m) 1.71  ± 0.01 1.71  ± 0.01 
 BMI (kg/m 2 ) 27.4  ± 1.1 27.4  ± 1.1 
 Leg volume (L) 8.2  ± 0.5 8.3  ± 0.5 * 
 Glucose (mmol/L) 5.6  ± 0.2 5.5  ± 0.1 
 HbA1c (%) 5.8  ± 0.1 5.7  ± 0.1 
 OGIS (mL/min/m 2 ) 368  ± 22 382  ± 19 
 1RM LE (kg) 88  ± 4 111  ± 5 * 
 1RM LP (kg) 170  ± 8 210  ± 10 * 
 Notes: Data are means  ± SEMs; BMI, body mass index; OGIS, oral glucose 
insulin sensitivity index ( 29 ); 1RM, one-repetition maximum; LE, leg exten-
sion; LP, leg press. 
 *  Signifi cantly different compared with before the intervention ( p < .05). 
  
 Figure 1.  Muscle fi ber type – specifi c analysis for satellite cell (SC) content. 
(A) myosin heavy chain-I  + laminin + 4,6-diamidino-2-phenylindole (DAPI) 
staining from serial cross-section of images (B – D); the marked area represents 
the same area as shown in frames (B – D); (B) CD56 + laminin + DAPI staining; 
(C) CD56 staining; (D) CD56 + DAPI staining. Arrows indicate the SCs. Num-
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 Dietary Records 
 Analysis of the 3-day dietary records before and after 
11 weeks of intervention did not show any changes in total 
daily energy intake (9.2  ± 0.6 vs 9.1  ± 0.4 MJ/day, respec-
tively). Likewise, macronutrient composition of the diet did 
not change during the intervention period, and averaged 
50  ± 2, 33  ± 2, and 17  ± 1 En% before intervention and 
52  ± 2, 32  ± 2, and 16  ± 1 En% after 11 weeks of interven-
tion, for carbohydrate, fat, and protein, respectively. Daily 
protein intake averaged 1.1  ± 0.1 g/kg body mass/day,  both 
before and after 11 weeks of intervention. 
 Muscle Fiber Type Composition and Fiber Area 
 At baseline, the proportion of Type I and Type II muscle 
fi bers was 47%  ± 4% and 53%  ± 4%, and the proportion of 
muscle area occupied by Type I and II fi bers was 52%  ± 4% 
and 48%  ± 4%, respectively. Muscle fi ber type percentage, 
expressed either as fi ber number or area occupied by Type I 
and Type II muscle fi bers, did not show any changes follow-
ing 3 months of exercise intervention ( Table 3 ). 
 For muscle fi ber CSA, a signifi cant  “ Time × Fiber type ” 
interaction was observed. At baseline, Type II muscle fi ber 
CSA was smaller than Type I muscle fi ber CSA ( Table 3 ,  p < 
.01). However, the difference in fi ber type CSA was no longer 
apparent after the intervention period, with a mean Type I and 
II muscle fi ber CSA of 6,881  ± 493 and 6,982  ± 503  m m 2 , 
respectively ( Table 3 ). In contrast to the Type I fi bers, Type II 
muscle fi ber CSA signifi cantly increased following exercise 
intervention from 5,438  ± 319 to 6,982  ± 503  m m 2 ( p < .01). 
 Myonuclear and SC Content 
 At baseline, the number of myonuclei per muscle fi ber 
was higher in the Type I versus Type II muscle fi bers (3.6  ± 
0.2 vs 2.8  ± 0.2, respectively;  p < .01). A signifi cant Time × 
Fiber type interaction revealed that after the exercise inter-
vention, differences in myonuclear content were no longer 
apparent between the Type I and II muscle fi bers (3.4  ± 0.3 
vs 3.3  ± 0.8, respectively). In contrast to the Type I fi bers, 
the number of myonuclei per Type II muscle fi ber tended to 
increase from 2.8  ± 0.2 to 3.3  ± 0.3 during the intervention 
program ( p = .091). Mean fi ber area per myonucleus was 
similar for the Type I and II muscle fi bers at baseline and 
did not change over time ( Table 4 ). 
 For all SC variables, signifi cant Time × Fiber type inter-
actions were observed. The number of SCs per muscle fi ber 
at baseline was lower for the Type II fi bers compared with 
the Type I fi bers (0.048  ± 0.003 vs 0.089  ± 0.006, respec-
tively;  p < .001). For the percentage of SCs and the number 
of SCs per square millimeter, analysis also revealed a sig-
nifi cantly lower SC content in the Type II versus Type I fi -
bers at baseline ( Table 4 ). In contrast to the Type I muscle 
fi bers, signifi cant increases were observed in the Type II 
muscle fi ber SC content after 3 months of exercise interven-
tion ( Figure 2 ,  Table 4 ). The number of SCs per Type II 
muscle fi ber increased substantially from 0.048  ± 0.003 to 
0.084  ± 0.008 ( p < .001), the percentage of SC increased 
from 1.8  ± 0.1 to 2.6  ± 0.3 ( p < .01), and the number of SCs 
per square millimeter of Type II fi ber area increased from 
9.2  ± 0.8 to 11.9  ± 0.9 ( p < .01). In accordance, after the 
intervention program, no differences in SC content were 
observed between the Type I and II muscle fi bers for any of 
the SC variables ( Figure 2 ,  Table 4 ). 
 Discussion 
 The present study shows that 3 months of resistance type 
exercise training augments muscle mass, reduces fat mass, 
and increases muscle strength in healthy, elderly men. The 
observed skeletal muscle hypertrophy is shown to be spe-
cifi c for the Type II muscle fi bers and accompanied by a 
specifi c increase in Type II muscle fi ber SC content. 
 Aging is associated with the loss of muscle mass, 
strength, and functional capacity ( 34 – 36 ). It has been well 
established that resistance type exercise training represents 
a feasible and effective interventional strategy to counteract 
sarcopenia in various elderly populations ( 14 – 19 , 21 , 22 , 
34 , 37 , 38 ). The resistance exercise program implemented in 
the present study was shown to be feasible, and resulted in 
a high compliance and adherence rate, with 35  ± 1 out of 36 
 Table 2.  Body Composition and Muscle Mass 
 Before After 
 Lean mass (kg) 57.4  ± 1.6 58.0  ± 1.7 
 Fat mass (kg) 19.6  ± 2.4 19.0  ± 2.4 * 
 Body fat (%) 23.6  ± 2.2 22.9  ± 2.2 * 
 Leg lean mass (kg) 18.3  ± 0.5 19.3  ± 0.5 * 
 Leg fat (%) 18.9  ± 2.3 18.3  ± 2.3 * 
 CSA (cm 2 ) 75.9  ± 3.7 82.4  ± 3.9 * 
 Notes: Data are means  ± SEMs; CSA, cross-sectional area of the right quad-
riceps muscle. 
 *  Signifi cantly different compared with before the intervention ( p < .05). 
 Table 3.  Muscle Fiber Type Composition 
 Before Intervention After Intervention 
 Fiber% CSA ( m m 2 ) CSA% Fiber% CSA ( m m 2 ) CSA% 
 Type I 47  ± 4 6,635  ± 354 52  ± 4 47  ± 3 6,881  ± 493 46  ± 3 
 Type II 53  ± 4 5,438  ± 319 * 48  ± 4 53  ± 3 6,982  ± 503  †  54  ± 3 
 Notes: Data are means  ± SEMs; CSA: fi ber cross-sectional area; CSA%: percentage area occupied by muscle fi ber type. 
 *  Signifi cantly different compared with the Type I muscle fi bers ( p < .01). 
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sessions being performed by the participants. In accor-
dance, we observed 25% – 30% improvements in 1RM 
strength for the LE and LP exercises. This increase in 
muscle strength is similar to previously published studies 
( 17 , 18 , 22 ). Skeletal muscle strength has been positively 
correlated with muscle mass and muscle CSA ( 34 , 35 ). In 
accordance, we observed a concomitant increase in leg lean 
mass (6%  ± 1%) and quadriceps CSA (9%  ± 1%;  Table 2 ). 
The latter clearly shows the effi cacy of the 12-week exer-
cise program to increase muscle mass and strength in 
healthy, elderly men. 
 Previous studies by other groups ( 1 – 3 ) as well as from our 
laboratory ( 4 ) have shown that the loss of muscle mass with 
aging is largely attributed to the specifi c atrophy of Type II 
muscle fi bers. In the present study, we confi rm a substantially 
smaller Type II muscle fi ber area when compared with Type 
I muscle fi bers at baseline in the elderly men ( Table 3 ). Fur-
thermore, we observed a signifi cantly lower myonuclear and 
SC content in the Type II versus Type I muscle fi bers prior to 
intervention ( Figure 2 ,  Table 4 ). The latter is consistent with 
our recent fi ndings showing a lower SC content in Type II 
muscle fi bers in muscle tissue from elderly versus young men 
( 4 ). In the present study, no young control group was in-
cluded, and Type II muscle fi ber characteristics at baseline 
could only be compared with Type I muscle fi bers, which 
were relatively large in the present study. However, the latter 
was probably due to the lower fi ber circularity as compared 
with our previous study (0.71 vs 0.74) ( 4 ). In addition, inter-
individual variability was large in the present study, with fi ber 
size ranging from 3,700 to 9,000  m m 2 . Despite these fi ndings, 
specifi c Type II muscle fi ber atrophy was still apparent when 
the present data were compared with the young control group 
in our previous study ( 4 ). Moreover, we ( 4 ) and others ( 33 ) 
have previously shown that SC content is similar between 
Type I and Type II muscle fi bers in young adults. Therefore, 
 Table 4.  Myonuclear and SC Content 
 Before After 
 Number of nuclei per fi ber  
  I 3.6  ± 0.2 3.4  ± 0.3 
  II 2.8  ± 0.2 * 3.3  ± 0.3 
 Fiber area per nucleus ( m m 2 )  
  I 1,918  ± 133 2,096  ± 118 
  II 2,029  ± 159 2,149  ± 148 
 Number of SCs per fi ber  
  I 0.089  ± 0.006 0.096  ± 0.011 
  II 0.048  ± 0.003 * 0.084  ± 0.008  †  
 SC %  
  I 2.6  ± 0.3 2.7  ± 0.3 
  II 1.8  ± 0.1 * 2.6  ± 0.3  †  
 Number of SCs per square millimeter  
 I 13.9  ± 1.2 12.9  ± 1.2 
  II 9.2  ± 0.8 * 11.9  ± 0.9  †  
 Notes: Data are means  ± SEMs; SC, satellite cells; SC%, number of SCs as 
a percentage of the total number of nuclei (ie, number of myonuclei + number 
of SCs); I, Type I muscle fi bers; II, Type II muscle fi bers. 
 *  Signifi cantly different compared with the Type I muscle fi bers ( p < .01). 
  †   Signifi cantly different compared with before the intervention ( p < .01). 
 Figure 2.  Mean number of satellite cells (SC) in the Type I and Type II 
muscle fi bers before and after the exercise intervention program.   #  Signifi cantly 
different compared with the Type I muscle fi bers ( p < .01); *signifi cantly differ-
ent compared with before the intervention ( p < .01). 
we argue that the lower fi ber size and SC content of the Type II 
versus Type I muscle fi bers at baseline in the present study 
are consistent with and indicative of the specifi c reduction of 
Type II muscle fi ber size and SC content with aging. Similar 
fi ber type – specifi c changes in SC content have also been ob-
served in animal studies ( 39 ). These data might suggest a 
causal relationship between a decline in myonuclear and/or 
SC content and muscle fi ber type – specifi c atrophy. The lower 
number of SCs might be insuffi cient to support myofi ber 
maintenance and, as such, contribute to the gradual loss of 
muscle mass with aging ( 39 ). Reduced neuromuscular activ-
ity (due to a more sedentary lifestyle and/or functional dis-
ability) and/or impaired neuronal input might represent 
important factors contributing to the age-related decline in 
myonuclear and SC number and activity and the associated 
reduction in muscle fi ber size ( 20 , 40 ). More research is war-
ranted to elucidate the potential role of the decline in Type II 
muscle fi ber SC content in the etiology of sarcopenia. 
 To further investigate the proposed functional relationship 
between the reduced SC content in the Type II versus Type I 
muscle fi bers and the accompanying smaller Type II muscle 
fi ber size in elderly men, it is of substantial clinical relevance 
to assess whether strategies that induce muscle fi ber hyper-
trophy are associated with an increase in muscle fi ber SC 
content. This would provide important novel information, of-
fering new targets for the evaluation of effective nutritional, 
pharmaceutical, and/or exercise interventions to combat sar-
copenia in older adults. Resistance type exercise training has 
been established as an effective therapeutic strategy to induce 
muscle hypertrophy in older adults and has been associated 
with a more pronounced hypertrophy of the Type II muscle 
fi bers ( 16 – 19 ). The latter is supported by the present fi ndings, 
as we observed a 28%  ± 6% increase in Type II muscle fi ber 
CSA following 12 weeks of training ( Table 3 ). Notably, dif-
ferences in fi ber size between Type I and II muscle fi bers as 
observed prior to intervention were no longer apparent after 
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 There has been much discrepancy in the literature on the 
proposed impact of resistance type exercise training on myo-
nuclear and/or SC content in muscle tissue in older adults 
( 9 , 21 – 23 ). The apparent discrepancy is likely attributed to 
the lack of fi ber type – specifi c data on muscle fi ber hypertro-
phy/atrophy and the associated changes in myonuclear and/
or SC content. In the present study, the specifi c hypertrophy 
of Type II muscle fi bers after training was accompanied by a 
substantial 76%  ± 15% increase in Type II muscle fi ber SC 
content ( Figure 2 ,  Table 4 ). In addition, the number of myo-
nuclei per Type II muscle fi ber tended to increase from 2.8  ± 0.2 
to 3.3  ± 0.3 ( p = .091), whereas the fi ber area per myonucleus 
was maintained throughout the intervention period ( p = .531; 
 Table 4 ). These fi ndings are in line with the rationale that 
myofi ber hypertrophy is facilitated by increased translational 
activity of preexisting myonuclei and/or the incorporation of 
newly formed myonuclei ( 11 , 41 , 42 ). Consequently, our fi nd-
ings suggest that the maximum amount of cytoplasm that can 
be controlled by one myonucleus, referred to as the  “ myonu-
clear domain ” ceiling ( 23 , 43 ), was reached during the inter-
vention program. Therefore, SC proliferation and the 
subsequent incorporation of their differentiated progeny (ie, 
newly formed myonuclei) was essential to allow further Type 
II muscle fi ber hypertrophy. In that respect, it was surprising 
that we only observed a tendency toward an increase in Type 
II muscle fi ber myonuclear content ( p = .091). However, as 
described by Petrella and coworkers ( 42 ) in their recent arti-
cle, the myofi ber response to an exercise program can be 
highly variable. By using cluster analysis, the authors re-
ported that participants with extreme myofi ber hypertrophy 
also showed the largest increases in SC content and both 
myonuclear number and domain size ( 42 ). In accordance, 
interindividual variability has an important role in the appar-
ent discrepancy between signifi cant myofi ber hypertrophy 
and nonsignifi cant changes in myonuclear content and/or do-
main as observed in the present and previous studies ( 9 , 23 ). 
Supposedly, some participants might have relied more heav-
ily on expansion of the myonuclear domain, whereas most 
participants were able to incorporate new myonuclei. In the 
present study, we observed a nonsignifi cant 25%  ± 12% in-
crease in the number of myonuclei per Type II muscle fi ber. 
The latter tends to be in line with the 26% increase observed 
by Petrella and coworkers ( 42 ). Because only pre- and 
postintervention biopsy samples were collected, we can only 
speculate on the proposed time line between an increase in 
SC number, the incorporation of new myonuclei, and subse-
quent muscle fi ber hypertrophy. However, in vitro data and 
rodent studies indicate that an increase in SC number and 
subsequent incorporation of new myonuclei precedes muscle 
hypertrophy (reviewed in ( 20 )). 
 Considering the large interindividual variability in the hy-
pertrophy response and the relations between the changes in 
myofi ber size, SC content, and myonuclear content, it is inter-
esting to speculate which factors might be responsible for the 
apparent differential responses. Previous research implicated 
that the myogenic regulatory factors (myogenin, MyoD, myf-5, 
and MRF4) and various growth agents such as insulin-like 
growth factor-I, mechano growth factor, and hepatocyte growth 
factor  have a role in the (load-mediated) hypertrophy and in SC 
activation and/or proliferation and differentiation (reviewed in 
( 6 , 44 )). However, most data are derived from in vitro and acute 
in vivo studies and, as such, little is known on the potential role 
these agents have in the response to prolonged exercise train-
ing. However, as we restricted ourselves to the assessment of 
the impact of exercise training on muscle fi ber characteristics, 
we can only speculate on this matter. 
 This is the fi rst study to show that the relatively lower Type II 
muscle fi ber size and SC content in older adults can be specifi -
cally enhanced following 3 months of resistance type exercise 
training. Though the exact signaling pathways leading to SC-
induced muscle fi ber hypertrophy as well as the reasons for 
interindividual response variability in these pathways remain 
to be elucidated, these fi ndings might open up novel opportuni-
ties for evaluating the effi cacy of nutritional, pharmaceutical, 
and/or exercise-based interventional strategies to counteract 
the loss of muscle mass, strength, and function with aging. 
 We conclude that prolonged resistance type exercise train-
ing effectively increases muscle mass and strength in healthy, 
elderly men. The relative Type II muscle fi ber atrophy and the 
associated lower SC content in Type II versus Type I muscle 
fi bers in older adults can be reversed by prolonged resistance 
type exercise training. The latter indicates that muscle tissue 
in older adults is still capable of inducing SC proliferation, 
differentiation, and fusion of new myonuclei into existing 
muscle fi bers, resulting in Type II muscle fi ber hypertrophy. 
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